Supply Chain
Merck & Co. received $1.4 billion from HHS in 2014, while Pfizer scored $856 million, according to report by analytics firm Govini.
Theranos technology can take a drop of blood from the finger and screen for a spectrum of conditions and diseases at half the price of Medicare.
Beyond incremental financial savings, if hospitals are able to effectively manage data in a way that fits the needs of their value analysis and revenue cycle teams, the operational efficiencies can be even more impactful.
In an era of declining reimbursements, hospital CFOs and CEOs will be forced to attack the second largest cost area for their organizations: supplies and service expense.
The FDA said the Olympus TJF-Q180V duodenoscope, one of the scopes tied to the CRE cases, is still pending clearance while being marketed to hospitals.
Genentech chose to move three lifesaving cancer drugs from traditional wholesale distribution channels to specialty distributors.
Don't downplay patient experience when making the choice, says Cone Health VP Mike Simms ahead of April's Revenue Cycle Summit.
Cordis had $780 million in sales in 2014, with about 70 percent coming from outside the U.S.
Nina Pham alleges the hospital knew of the impending medical crisis yet failed to provide training and proper equipment, including protective gear, to treat Ebola patients.
Healthcare Solutions services the workers' compensation market.